Nasal hyposensitization and hay fever.

Area of Science:

• Allergy and Immunology
• Respiratory Medicine

Background:

• Seasonal allergic rhinitis, commonly known as hay fever, significantly impacts quality of life.
• Traditional treatments include avoidance, pharmacotherapy, and allergen immunotherapy (AIT).
• Intra-nasal administration of allergen extracts presents a potentially simpler alternative to injection-based AIT.

Purpose of the Study:

• To evaluate the efficacy of pre-seasonal intra-nasal grass pollen extract hyposensitization.
• To compare the effectiveness of intra-nasal hyposensitization with a placebo and with traditional injection methods.

Main Methods:

• A clinical trial involving 42 patients with grass pollen allergy.
• Pre-seasonal administration of intra-nasal grass pollen extract or a carbol saline placebo.
• Assessment of symptom relief through subjective reporting, clinical examination, and nasal airflow measurements.

Main Results:

• 15 out of 21 patients receiving pollen extract reported useful symptom relief.
• 5 out of 21 patients receiving the placebo reported useful symptom relief.
• 10 out of 12 patients who were symptom-free during the pollen season had undergone nasal hyposensitization.

Conclusions:

• Pre-seasonal intra-nasal grass pollen extract hyposensitization is an effective treatment for allergic rhinitis.
• This method provides symptom relief comparable to conventional pre-seasonal injection immunotherapy.
• The intra-nasal approach is a simple and safe alternative for managing hay fever.